title: Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia.
abstract: BACKGROUND
  The Brief Assessment of Cognition in Schizophrenia (BACS) is an evaluation of cognitive function that can be completed with more cases. However, there are few studies that compare which factor, disease or aging, is a better determinant of performance on the BACS. The present study aimed to investigate the influences of disease and aging on BACS performance in schizophrenic patients using subjects with a wide range of ages.
  
  
  METHODS
  Schizophrenic patients (n = 165) and a comparison group (n = 171) were recruited as subjects. All participants completed the Japanese language version of the BACS (BACS-J), and the influences of disease and aging on performance in the BACS were examined with the use of multiple regression analysis.
  
  
  RESULTS
  There was a significant influence of diagnosis and level of education on all six tasks of the BACS and the performance and composite scores. In addition, age was found to influence five tasks and the composite score, the duration of illness influenced four tasks and the composite score, and gender influenced one task and the composite score.
  
  
  CONCLUSIONS
  The present study suggests that performance on the BACS was impaired not only by disease but also by level of education and aging.
authors: Department of Neuropsychiatry, Hirosaki University Graduate School of Medicine, Hirosaki, Japan ; Department of Psychiatry, Kuroishi-Akebono Hospital, Kuroishi, Japan.
authors: Ayako
authors: A
authors: Kaneda
authors: Takeshi
authors: T
authors: Katagai
authors: Norio
authors: N
authors: Yasui-Furukori
keywords: age; cognition; schizophrenia
references: Schizophr Res. 2009 Feb;107(2-3):255-61
references: 19004617
references: Biol Psychiatry. 1997 Jul 15;42(2):104-15
references: 9209727
references: J Psychopharmacol. 2012 Jun;26(6):806-12
references: 21616975
references: Arch Gen Psychiatry. 2007 May;64(5):532-42
references: 17485605
references: Biol Psychiatry. 1999 Oct 1;46(7):1003-5
references: 10509184
references: Psychiatry Res. 2011 Jun 30;188(1):7-12
references: 21126773
references: Iran J Psychiatry. 2012 Winter;7(1):22-5
references: 23056113
references: Aging Clin Exp Res. 2011 Apr;23(2):135-44
references: 21743291
references: Biol Psychiatry. 1999 Jan 1;45(1):32-40
references: 9894573
references: Neurosci Res. 2010 Apr;66(4):340-4
references: 20025912
references: Schizophr Res. 2008 Jul;102(1-3):108-15
references: 18495435
references: Cogn Neuropsychiatry. 2010 Jul;15(4):397-405
references: 20094930
references: Schizophr Bull. 2011 Nov;37(6):1318-26
references: 20547571
references: J Psychopharmacol. 2010 Jul;24(7):1037-44
references: 19164494
references: Exp Aging Res. 1991 Winter;17(4):227-42
references: 1820288
references: Am J Psychiatry. 1998 Oct;155(10):1358-64
references: 9766767
references: Aging Ment Health. 2010 Jul;14(5):587-92
references: 20614347
references: Schizophr Res. 2004 Jun 1;68(2-3):283-97
references: 15099610
references: Am J Geriatr Psychiatry. 2010 Oct;18(10):908-16
references: 20808150
references: Percept Mot Skills. 1993 Jun;76(3 Pt 2):1219-30
references: 8337069
references: Psychiatry Clin Neurosci. 2007 Dec;61(6):602-9
references: 18081619
references: Am J Geriatr Psychiatry. 2012 Jan;20(1):29-40
references: 22130385
references: Hum Brain Mapp. 2011 Feb;32(2):282-9
references: 20336658
references: J Clin Exp Neuropsychol. 2008 Feb;30(2):199-203
references: 18938671
references: Psychiatry Clin Neurosci. 2006 Jun;60(3):332-9
references: 16732750
references: Acta Psychiatr Scand Suppl. 2000;401:3-38
references: 10887978